Eugia Pharma Specialities Limited Anastrozole Export Data — India (DGFT 2022–2026)

Name: Eugia Pharma Specialities Limited Anastrozole Export Records India — #3 Exporter, 116 Shipments, $3.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Anastrozole

India Pharmaceutical Trade Intelligence

$110.7M158 Suppliers99 CountriesHS 30049099

ExportsIndia → UNITED STATES92.3%India → BRAZIL1.9%

ImportsUNITED STATES → India$10.5M ISRAEL → India$2.0M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: EVERSANA LIFE

Eugia Pharma Specialities Limited — Anastrozole Exporter #3 | $3.5M Trade Value | TransData Nexus | TransData Nexus

Eugia Pharma Specialities Limited — Anastrozole Exporter Profile

Indian Pharmaceutical Exporter · #3 for Anastrozole · $3.5M export value · DGFT Verified

Eugia Pharma Specialities Limited is the #3 Indian exporter of Anastrozole with $3.5M in export value and 116 verified shipments. Eugia Pharma Specialities Limited holds a 3.2% market share in Anastrozole exports across 6 countries. The company exports 49 pharmaceutical products worth $170.1M across 14 therapeutic categories.

Eugia Pharma Specialities Limited — Anastrozole Export Profile: Buyers & Destinations

Eugia Pharma Specialities Limited Anastrozole export treemap — buyers and destination countries | TransData Nexus

Where Does Eugia Pharma Specialities Limited Export Anastrozole?

Country	Value	Shipments	Share
UNITED STATES	$1.9M	43	80.4%
MALTA	$240.6K	54	10.1%
UNITED STATES OF AMERICA	$100.0K	2	4.2%
KAZAKISTAN	$67.1K	8	2.8%

Who Are the Top Buyers of Anastrozole from Eugia Pharma Specialities Limited?

Buyer	Country	Value	Orders
AUROBINDO PHARMA USA., INC,	UNITED STATES	$1.1M	25
AUROBINDO PHARMA USA INC	UNITED STATES OF AMERICA	$400.0K	8
AUROLOGISTICS LLC, (AUROBINDO PHARM	UNITED STATES	$292.1K	7
AUROBINDO PHARMA USA., INC	UNITED STATES	$100.0K	2
AUROLOGISTICS LLC AUROBINDO PHARM	UNITED STATES	$94.6K	2
APL SWIFT SERVICES (MALTA) LTD.,	MALTA	$59.1K	7
AUROBINDO PHARMA USA.INC.,.	UNITED STATES	$50.0K	1
EUGIA PHARMA (MALTA) LIMITED	MALTA	$46.9K	9
APL SWIFT SERVICES MALTA LTD	MALTA	$44.3K	3
MILPHARM,	UNITED KINGDOM	$34.0K	1

Eugia Pharma Specialities Limited supplies Anastrozole to 22 buyers globally. The largest buyer is AUROBINDO PHARMA USA., INC, (UNITED STATES), followed by AUROBINDO PHARMA USA INC (UNITED STATES OF AMERICA) and AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Anastrozole Formulations Does Eugia Pharma Specialities Limited Export?

Product Description / Formulation	Value	Shipments
ANASTROZOLE TABLETS 1MG (ANASTROZOLE TAB	$349.7K	7
ANASTROZOLE TABLETS 1MG Anastrozole Tablets USP 1mg 54768X90 S	$100.0K	2
ANASTROZOLE TABLETS 1MG Anastrozole Tablets USP 1mg 55505X30 S	$100.0K	2
ANASTROZOLE TABLETS 1MG (18480X90'S)	$96.9K	2
ANASTROZOLE TABLETS 1MG (ANASTROZOLE TABLETS USP 1MG) (36842X90'S)NOS	$96.4K	3
ANASTROZOLE TABLETS 1MG (ANASTROZOLE TABLETS USP 1MG - US (90 S COUNT)) (QTY: 36937 PACKS)NOS	$94.6K	3
ANASTROZOLE TABLETS 1MG 55725X30 S	$50.0K	1
ANASTROZOLE TABLETS 1MG (ANASTROZOLE TABLETS USP 1MG FOR 30S COUNT US MARKET) (QTY: 55056 PACKS)	$50.0K	1
ANASTROZOLE TABLETS 1MG(ANASTROZOLE TABLETS USP 1MG - US (90 S COUNT)) (QTY: 55080 PACKS)	$50.0K	1
ANASTROZOLE TABLETS 1MG ANASTROZOLE TABLETS USP 1MG - US 90 S COUNT QTY: 55749 PACKS	$50.0K	1

Eugia Pharma Specialities Limited exports 80 distinct Anastrozole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ANASTROZOLE TABLETS 1MG (ANASTROZOLE TAB with 7 shipments worth $349.7K.

How Does Eugia Pharma Specialities Limited Compare to Nearest Anastrozole Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	INTAS PHARMACEUTICALS LIMITED	$10.4M	209	13	$50.0K
2	ZYDUS LIFESCIENCES LIMITED	$3.6M	111	3	$32.4K
3	EUGIA PHARMA SPECIALITIES LIMITED ★	$3.5M	116	6	$30.4K
4	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$3.1M	70	5	$44.9K
5	NATCO PHARMA LIMITED	$2.7M	68	10	$39.5K

Eugia Pharma Specialities Limited ranks #3 among 158 Indian Anastrozole exporters. Average shipment value of $30.4K compared to the market average of $163.1K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and ZYDUS LIFESCIENCES LIMITED.

Which Indian Ports Ship Anastrozole Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	465	20.8%
SAHAR AIR	391	17.5%
DELHI AIR CARGO ACC (INDEL4)	280	12.5%
DELHI AIR	167	7.5%
MUNDRA SEA	90	4.0%
Bombay Air	86	3.8%
HYDERABAD AIR	75	3.4%
MUNDRA SEA (INMUN1)	70	3.1%

Geopolitical & Trade Policy Impact on Eugia Pharma Specialities Limited's Anastrozole Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Eugia. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These logistical hurdles are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in supply chain management. (pharmaceuticalcommerce.com)

Conversely, U.S.-China trade tensions have opened avenues for Indian exporters. With the U.S. seeking to diversify its supply chains away from China, Indian pharmaceutical companies have the opportunity to capture a larger share of the U.S. market. Eugia's recent FDA approvals and product launches position it well to capitalize on this shift.

However, the imposition of new tariffs by the U.S. administration in August 2025, affecting over 60 countries including India, poses a significant challenge. These tariffs, reaching up to 39%, could impact nearly 55% of India's exports to the U.S., including pharmaceuticals. The increased cost burden may erode profit margins and affect competitiveness in the U.S. market. (apnews.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement. Indian exporters must ensure stringent adherence to serialization and traceability standards to maintain access to the EU market. Eugia's commitment to quality and regulatory compliance will be pivotal in navigating these regulatory landscapes.

Eugia Pharma Specialities Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the USFDA intensifying inspections and compliance requirements. Eugia's experience with the USFDA's warning letter for its Unit-III facility underscores the importance of robust quality management systems. Addressing these regulatory observations is crucial for maintaining market access and reputation.

Indian pharmaceutical companies, including Eugia, are investing in upgrading manufacturing practices to meet international standards. This proactive approach is essential to mitigate risks associated with non-compliance and to sustain growth in regulated markets.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Anastrozole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Eugia Pharma Specialities Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 116 individual customs records matching Eugia Pharma Specialities Limited exporting Anastrozole, covering 80 formulations to 7 countries via 22 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 99+ countries, 387+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Anastrozole

Anastrozole

Eugia Pharma Specialities Limited — Anastrozole Exporter Profile

Eugia Pharma Specialities Limited — Anastrozole Export Profile: Buyers & Destinations

Where Does Eugia Pharma Specialities Limited Export Anastrozole?

Who Are the Top Buyers of Anastrozole from Eugia Pharma Specialities Limited?

What Is India's Total Anastrozole Export Value and How Much Does Eugia Pharma Specialities Limited Contribute?

What Is the Average Shipment Value for Eugia Pharma Specialities Limited's Anastrozole Exports?

How Does Eugia Pharma Specialities Limited Compare to Other Indian Anastrozole Exporters?

What Anastrozole Formulations Does Eugia Pharma Specialities Limited Export?

Regulatory Requirements: Exporting Anastrozole to Key Markets

United States — FDA

How Does Eugia Pharma Specialities Limited Compare to Nearest Anastrozole Exporters?

Which Indian Ports Ship Anastrozole Exports?

What Other Advanced Oncology Products Does Eugia Pharma Specialities Limited Export?

Anastrozole — Export Intelligence Video

Geopolitical & Trade Policy Impact on Eugia Pharma Specialities Limited's Anastrozole Exports

Eugia Pharma Specialities Limited — Regulatory Compliance & Quality Standards

About Eugia Pharma Specialities Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Anastrozole Export Data from Eugia Pharma Specialities Limited

Anastrozole Stats

Company Overview

Top Products by Eugia Pharma Specialities Limited

Related Analysis

Need Detailed Export Data?

Data Source